Scientists have moved one step closer to developing a capsule that can potentially alter the treatment paradigm from painful intravenous injections currently used to treat an advanced form of cancers such as melanoma, lung cancer, and advanced renal cell carcinoma.
Checkpoint inhibitors or the mechanism of blocking proteins that are expressed on cancer cells or immune cells in the human body and trigger the body’s immune system to fight cancer cells is the latest frontier in cancer research with large drug makers pumping in billions of dollars in search of effective leads.
No comments:
Post a Comment